Cardio Diagnostics - CDIO Net Assets per Single Share

Graphic logo of Cardio Diagnostics (CDIO)

The integration of AI tests into medical protocols ensures a steady stream of orders for Cardio Diagnostics. The GURU.Markets system generates this chart, where the net asset value per ordinary share reflects current capitalization, while the 2.53 indicator determines the parameter status. The strategy is based on the diversification of sales channels as management adjusts expenses amid limited liquidity.

Cardio Diagnostics Holdings, Inc. (CDIO) - Accounting Value per Share from 04/28/2023 to 10/26/2026

Summary analytical data breakdowns for Cardio Diagnostics Holdings Inc. (CDIO)

- price and consensus price forecast:
Stock Price Cardio Diagnostics Holdings, Inc.|CDIO - Analyst Median Target
- market capitalization data:
Market Value Cardio Diagnostics Holdings|CDIO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Cardio Diagnostics|CDIO - Company Net Assets|Market Capitalization to Book Value Ratio cardiodiagnosticsinc.com|CDIO - Company Assets
- debt and liquidity data:
Total Debt to Capital Cardio Diagnostics|CDIO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cardio Diagnostics Holdings, Inc.|CDIO - Company Aggregate Debts|Debt to Book Capitalization Ratio Cardio Diagnostics Holdings
Fundamental company valuation: Cardio Diagnostics
Manufactured product of Cardio Diagnostics Holdings Inc.

The deployment of the EpiCheck AI platform for predictive DNA marker analysis forms the foundation of high-tech intangible assets for Cardio Diagnostics (CDIO). The trend in the target book value per share, calculated as the difference between total assets and liabilities divided by the number of shares, reflects the real value of net assets, allowing investors to assess the internal capitalization and resilience of Cardio Diagnostics (CDIO) against potential write-downs.

Competitors of Cardio Diagnostics (CDIO)

Book Value per Share A (Agilent Tech)|DGX: Net Assets per Share|Net Assets per Single Share ILMN|EXAS (exactsciences.com) - Net Asset Value per Share|Net Assets per Single Share RVTY|Accounting Value per Share Bio-Rad Laboratories, Inc.|Anbio Tech - Book Value per Share|Net Asset Value per Share Nordion (SHC)|QDEL - Book Value per Share|Equity per Share opko.com OPK|CareDx, Inc - Book Value per Share|MRVI: Book Value per Share|Net Assets per Single Share Fulgent Corp|Standard BioTools Corp (LAB) - Equity per Share|CTKB (Cytek Biosciences, Inc.) - Book Value per Share|Book Value per Share OSUR|Net Assets per Single Share Exagen Inc. (XGN)|Net Assets per Single Share MDxHealth S.A. MDXH|LUCD: Accounting Value per Share|Prenetics Global Limited - Net Asset Value per Share|Net Assets per Single Share IMDX (Insight Molecular)|TRIB - Net Assets per Share|ProPhase Labs - Book Value per Share|AIMD (Ainos Inc) - Net Assets per Share|CODX: Net Assets per Single Share|Net Assets per Share Heart Test Labs|Book Value per Share BMRA (Biomerica, Inc.)|Accounting Value per Share viraxbiolabs.com (VRAX)|Book Value per Share BJDX (Bluejay Diagnostics, Inc.)|Aspira Women's Health, Inc. - Book Value per Share|Net Assets per Single Share Accelerate Diagnostics, Inc (AXDX)|CNTG - Accounting Value of a Share|Book Value per Share enzo.com|Fresh2 Group (FRES) - Equity per Share|GENE: Book Value per Share|Net Assets per Share ME|Psychemedics Corp - Net Assets per Single Share